CONCLUSIONS: Baseline cachexia was associated with a higher burden of early hematologic toxicity and independently worse OS in EGFR-mutated advanced NSCLC treated with EGFR-TKIs. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.